Yoko Nukui

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer et al. · Science Immunology · 2021 · 600 citations · Full text

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 180 citations · Full text

Ifn Autoantibodies, Immunology, Age Dependent +16

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia

Yoko Nukui, Shuji Hatakeyama, Koh Okamoto et al. · Journal of Antimicrobial Chemotherapy · 2013 · 174 citations

Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan

Shuji Hatakeyama, Yuki Ohama, Mitsuhiro Okazaki et al. · BMC Infectious Diseases · 2017 · 74 citations · Full text

A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice

Shigeru Tajima, Reiko Nerome, Yoko Nukui et al. · Virology · 2009 · 56 citations

Molecular Virology, Mouse Neuroblastoma Cells, Growth Rate +9